7,640.25

+26.25

+0.34%

52,139.00

+221.00

+0.43%

28,706.00

+172.00

+0.60%

Russell 2000 Futures

2,834.50

+13.20

+0.47%

4.9170

-0.0120

-0.24%

19.54

+0.12

+0.62%

3,922.50

+23.60

+0.61%

78,025.29

+132.20

+0.17%

Crude Oil Dec 26

99.66

-4.46

-4.28%

US Private Equity

10,850.63

-82.20

-0.75%

Frankfurt - Delayed Quote EUR

Thermo Fisher Scientific Inc. (TN8.F)

626.00 +5.60 (+0.90%)

As of 11:39:56 AM GMT+1. Market Open.

Loading Chart for TN8.F

Chart Range Bar

Interval:

In partnership with ChartIQ

What Sent Illumina Stock Lower?

What Sent Illumina Stock Lower?

Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q3 Beat And Higher Guidance

Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q3 Beat And Higher Guidance

How Investors Are Reacting To Thermo Fisher Scientific Stock After Strong Q3 Earnings

How Investors Are Reacting To Thermo Fisher Scientific Stock After Strong Q3 Earnings

Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN

Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN

Clinical Genomics Interpretation Platforms Global Market Report 2026 | Capitalize on AI and Cloud Growth Through 2030 with Thermo Fisher, Illumina, QIAGEN, and Tempus AI

Clinical Genomics Interpretation Platforms Global Market Report 2026 | Capitalize on AI and Cloud Growth Through 2030 with Thermo Fisher, Illumina, QIAGEN, and Tempus AI

Global Ribonucleic Acid (RNA) Interference Technology Market Report 2026-2030 | Capitalize on Precision Gene Silencing with Alnylam, Arrowhead, Silence Therapeutics, and Roche

Global Ribonucleic Acid (RNA) Interference Technology Market Report 2026-2030 | Capitalize on Precision Gene Silencing with Alnylam, Arrowhead, Silence Therapeutics, and Roche

Clinical Genomics Sequencing, Biobank, and Database Services Global Market to 2035 | Capitalize on AI and Precision Medicine: Illumina, Thermo Fisher, BGI Genomics, Tempus AI

Clinical Genomics Sequencing, Biobank, and Database Services Global Market to 2035 | Capitalize on AI and Precision Medicine: Illumina, Thermo Fisher, BGI Genomics, Tempus AI

Global CRISPR Fluorescence Assays Market Report 2026 | Capitalize on 19.5% CAGR to 2030 with Thermo Fisher, Merck, QIAGEN, and Mammoth Biosciences Driving Multiplex Diagnostics

Global CRISPR Fluorescence Assays Market Report 2026 | Capitalize on 19.5% CAGR to 2030 with Thermo Fisher, Merck, QIAGEN, and Mammoth Biosciences Driving Multiplex Diagnostics

Global Fetal Aneuploidy Confirmation Testing Market Report 2026 | Capitalize on 10.6% CAGR to $2.36 Billion by 2030 with Thermo Fisher, Labcorp, Quest Diagnostics and Illumina

Global Fetal Aneuploidy Confirmation Testing Market Report 2026 | Capitalize on 10.6% CAGR to $2.36 Billion by 2030 with Thermo Fisher, Labcorp, Quest Diagnostics and Illumina

Global Gene Panel Reconciliation Services Market Report 2026 | Capitalize on AI-Driven Genomics as Roche, Thermo Fisher, Illumina and QIAGEN Accelerate a $2.38B Market by 2030

Global Gene Panel Reconciliation Services Market Report 2026 | Capitalize on AI-Driven Genomics as Roche, Thermo Fisher, Illumina and QIAGEN Accelerate a $2.38B Market by 2030

Illumina Sinks 13% on Light Q3 Revenue Despite EPS Beat and Raised Guidance

Illumina Sinks 13% on Light Q3 Revenue Despite EPS Beat and Raised Guidance

Mobilize your Website

View Site in Mobile | Classic

Share by: